No connection

Search Results

BGM vs GDRX

BGM
BGM Group Ltd.
BEARISH
Price
$3.72
Market Cap
$746.3M
Sector
Healthcare
AI Confidence
85%
GDRX
GoodRx Holdings, Inc.
BEARISH
Price
$2.16
Market Cap
$740.0M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
BGM
--
GDRX
24.0
Forward P/E
BGM
--
GDRX
5.88
P/B Ratio
BGM
2.01
GDRX
1.2
P/S Ratio
BGM
24.99
GDRX
0.93
EV/EBITDA
BGM
-29.15
GDRX
8.35

Profitability

Gross Margin
BGM
2.92%
GDRX
92.77%
Operating Margin
BGM
-5.41%
GDRX
18.98%
Profit Margin
BGM
-26.32%
GDRX
3.82%
ROE
BGM
-16.52%
GDRX
4.54%
ROA
BGM
-3.84%
GDRX
4.75%

Growth

Revenue Growth
BGM
-56.9%
GDRX
-1.9%
Earnings Growth
BGM
0.0%
GDRX
-9.7%

Financial Health

Debt/Equity
BGM
0.0
GDRX
0.88
Current Ratio
BGM
7.05
GDRX
2.61
Quick Ratio
BGM
5.94
GDRX
2.1

Dividends

Dividend Yield
BGM
--
GDRX
--
Payout Ratio
BGM
0.0%
GDRX
0.0%

AI Verdict

BGM BEARISH

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score and negative profitability metrics raise concerns. The company is unprofitable with a -26.32% profit margin, -5.41% operating margin, and negative ROE and ROA, while revenue has collapsed by 56.90% year-over-year. Valuation multiples are extremely high with a Price/Sales ratio of 24.99 despite deteriorating fundamentals, and the stock has lost 90.8% of its value over five years. Although the balance sheet shows no debt and strong liquidity ratios, the lack of earnings, cash flow data, and analyst coverage suggests high uncertainty and limited investor confidence.

Strengths
Piotroski F-Score of 6/9 indicates stable financial health relative to distressed peers
Exceptionally strong liquidity with a Current Ratio of 7.05 and Quick Ratio of 5.94
Zero debt (Debt/Equity = 0.00), reducing solvency risk
Risks
Severe profitability issues: -26.32% profit margin and -16.52% ROE
Catastrophic revenue decline of -56.90% YoY, far worse than peer average
Price/Sales of 24.99 is extremely high for a shrinking, unprofitable company
GDRX BEARISH

GDRX exhibits a fragile financial profile with a Piotroski F-Score of 4/9, indicating only marginal stability. The stock is currently trading at $2.16, which is a premium to its Graham Number ($1.91) and significantly above its growth-based intrinsic value ($0.63). Fundamental decay is evident through negative YoY revenue (-1.90%) and earnings growth (-9.70%), compounded by a streak of four consecutive earnings misses. With a 5-year price collapse of 94.7% and bearish insider sentiment, the data suggests a company in a structural decline.

Strengths
Exceptionally high gross margins (92.77%)
Strong short-term liquidity with a current ratio of 2.61
Low Price-to-Sales ratio (0.93) suggesting low valuation relative to revenue
Risks
Negative revenue and earnings growth trends
Consistent failure to meet analyst earnings estimates (0/4 last 4 quarters)
Severe long-term price erosion (-94.7% over 5 years)

Compare Another Pair

BGM vs GDRX: Head-to-Head Comparison

This page compares BGM Group Ltd. (BGM) and GoodRx Holdings, Inc. (GDRX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile